Search research articles
Contact Us
Filters
Showing results (11-20 of 157) with videos related to
Page
of 16
Sort By:
Breast Cancer Research and Treatment
|
February 13, 2013
A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians
Laetitia Huiart, Cyril Ferdynus, Roch Giorgi
Lancet (London, England)
|
June 18, 2013
Tamoxifen therapy for patients with breast cancer
Laetitia Huiart, Cyril Ferdynus, Roch Giorgi
Bulletin Du Cancer
|
October 12, 2013
[The importance of adherence to oral therapies in the field of oncology: the example of breast cancer]
Laetitia Huiart, Valérie-Jeanne Bardou, Roch Giorgi
Studies in Health Technology and Informatics
|
April 14, 2016
Interactive Videos within an e-Learning Context
Jean-Charles Dufour, Alain Emeric, Roch Giorgi
Statistics in Medicine
|
July 21, 2010
Flexible modeling of competing risks in survival analysis
Aurélien Belot, Michal Abrahamowicz, Laurent Remontet, et al.
Cardiology
|
May 11, 2020
Authors' Reply to the Letter by Shoar et al. on "Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo"
Pierre Ambrosi, Aurélie Daumas, Patrick Villani, et al.
Bulletin Du Cancer
|
December 1, 2005
[Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district]
Roch Giorgi, Julie Reynaud, Suzanne Wait, et al.
Statistics in Medicine
|
March 19, 2014
A joint frailty model to estimate the recurrence process and the disease-specific mortality process without needing the cause of death
Aurélien Belot, Virginie Rondeau, Laurent Remontet, et al.
Journal of Medical Screening
|
August 26, 2015
PAP assays in newborn screening for cystic fibrosis: a population-based cost-effectiveness study
Valerie Seror, Caroline Cao, Michel Roussey, et al.
Cardiology
|
February 24, 2020
Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo
Pierre Ambrosi, Aurélie Daumas, Patrick Villani, et al.
Page
of 16
Search research articles
Search
Showing results (11-20 of 157) with videos related to
Sort By:
Page
of 16
Breast Cancer Research and Treatment
|
February 13, 2013
A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians
Laetitia Huiart, Cyril Ferdynus, Roch Giorgi
Lancet (London, England)
|
June 18, 2013
Tamoxifen therapy for patients with breast cancer
Laetitia Huiart, Cyril Ferdynus, Roch Giorgi
Bulletin Du Cancer
|
October 12, 2013
[The importance of adherence to oral therapies in the field of oncology: the example of breast cancer]
Laetitia Huiart, Valérie-Jeanne Bardou, Roch Giorgi
Studies in Health Technology and Informatics
|
April 14, 2016
Interactive Videos within an e-Learning Context
Jean-Charles Dufour, Alain Emeric, Roch Giorgi
Statistics in Medicine
|
July 21, 2010
Flexible modeling of competing risks in survival analysis
Aurélien Belot, Michal Abrahamowicz, Laurent Remontet, et al.
Cardiology
|
May 11, 2020
Authors' Reply to the Letter by Shoar et al. on "Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo"
Pierre Ambrosi, Aurélie Daumas, Patrick Villani, et al.
Bulletin Du Cancer
|
December 1, 2005
[Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district]
Roch Giorgi, Julie Reynaud, Suzanne Wait, et al.
Statistics in Medicine
|
March 19, 2014
A joint frailty model to estimate the recurrence process and the disease-specific mortality process without needing the cause of death
Aurélien Belot, Virginie Rondeau, Laurent Remontet, et al.
Journal of Medical Screening
|
August 26, 2015
PAP assays in newborn screening for cystic fibrosis: a population-based cost-effectiveness study
Valerie Seror, Caroline Cao, Michel Roussey, et al.
Cardiology
|
February 24, 2020
Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo
Pierre Ambrosi, Aurélie Daumas, Patrick Villani, et al.
Page
of 16